
### [MONDO:0017779](http://purl.obolibrary.org/obo/MONDO_0017779)
**Label:** alpha-N-acetylgalactosaminidase deficiency

**Subclasses:** [MONDO:0012221](http://purl.obolibrary.org/obo/MONDO_0012221) (alpha-N-acetylgalactosaminidase deficiency type 1), 

**Corr. equiv. classes:** [Orphanet:79281](http://www.orpha.net/ORDO/Orphanet_79281), [Orphanet:3137](http://www.orpha.net/ORDO/Orphanet_3137), [OMIM:609241](http://purl.obolibrary.org/obo/OMIM_609241), [Orphanet:79279](http://www.orpha.net/ORDO/Orphanet_79279), 

**Class expressions from DL-Learner:**

- [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) and [HP:0100704](http://purl.obolibrary.org/obo/HP_0100704) (Cortical visual impairment) 62.50%
- [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) and [HP:0012795](http://purl.obolibrary.org/obo/HP_0012795) (Abnormality of the optic disc) 62.50%
- [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 62.50%
- [HP:0010864](http://purl.obolibrary.org/obo/HP_0010864) (Intellectual disability, severe) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 62.50%
- [HP:0004349](http://purl.obolibrary.org/obo/HP_0004349) (Reduced bone mineral density) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 62.50%
- [HP:0004348](http://purl.obolibrary.org/obo/HP_0004348) (Abnormality of bone mineral density) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 62.50%
- [HP:0003700](http://purl.obolibrary.org/obo/HP_0003700) (Generalized amyotrophy) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 62.50%
- [HP:0003593](http://purl.obolibrary.org/obo/HP_0003593) (Infantile onset) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 62.50%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0100704](http://purl.obolibrary.org/obo/HP_0100704) (Cortical visual impairment) 62.50%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0012795](http://purl.obolibrary.org/obo/HP_0012795) (Abnormality of the optic disc) 62.50%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 62.50%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0010864](http://purl.obolibrary.org/obo/HP_0010864) (Intellectual disability, severe) 62.50%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0004349](http://purl.obolibrary.org/obo/HP_0004349) (Reduced bone mineral density) 62.50%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0004348](http://purl.obolibrary.org/obo/HP_0004348) (Abnormality of bone mineral density) 62.50%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0003700](http://purl.obolibrary.org/obo/HP_0003700) (Generalized amyotrophy) 62.50%


